Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 09 Dec 2024 – 20 Aug 2026, limited by Nippon India Nifty Realty Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Nippon India Nifty Realty Index Fund | Nifty 500 |
|---|---|---|
| 09 Dec 2024 | ₹100.00 | ₹100.00 |
| 30 Jan 2025 | ₹83.85 | ₹91.44 |
| 22 Mar 2025 | ₹79.94 | ₹91.34 |
| 13 May 2025 | ₹80.14 | ₹95.95 |
| 03 Jul 2025 | ₹88.87 | ₹100.99 |
| 24 Aug 2025 | ₹84.04 | ₹98.71 |
| 15 Oct 2025 | ₹84.51 | ₹100.37 |
| 05 Dec 2025 | ₹82.37 | ₹102.33 |
| 26 Jan 2026 | ₹69.72 | ₹97.48 |
| 18 Mar 2026 | ₹67.25 | ₹94.10 |
| 09 May 2026 | ₹75.67 | ₹99.24 |
| 29 Jun 2026 | ₹75.13 | ₹98.75 |
| 20 Aug 2026 | ₹83.48 | ₹100.95 |
| Metric | Nippon India · Regular NAV ₹8.34 Very High risk ★☆☆☆☆ 1Y | Category median Index Funds · 366 funds |
|---|---|---|
| -1.08% | +5.43% | |
| — | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| -10.11% | +7.40% | |
| +3.93% | — | |
| — | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 27.87% | 13.88% | |
| -0.27 | 0.25 | |
| -0.38 | 0.35 | |
| -42.26% | -16.66% | |
| Nifty 500 | — | |
| — | +0.30% | |
| — | 1.00 | |
| — | 101.3% | |
| — | 98.8% | |
| 1.11% | 0.96% | |
| ₹44.27Cr | ₹182.17Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 59% | 35% | |
| Jitendra Tolani · 1.6y | — | |
| 09 Dec 2024 | — | |
| 10 | — | |
| 99.8% | — | |
| 0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.